Caffeine trial aims to keep preterm babies breathing safely at home

NCT ID NCT06518603

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving caffeine citrate to moderately preterm infants for 28 days after hospital discharge can prevent apnea (breathing pauses) that lead to sick visits. About 340 babies in Zambia will receive either caffeine or a placebo daily. Researchers will also check if caffeine improves the babies' development at 12 months of age.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
caffeine citrate
What this could lead to
If it works, this could reduce dangerous breathing pauses and emergency visits in preterm babies after they go home, and possibly improve their development at one year.
What could go wrong
This is a Phase 4 trial, but it's still early to know if caffeine helps after discharge. The study is in one country (Zambia), so results may not apply everywhere. Caffeine can cause side effects like jitteriness or fast heart rate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APNEA OF PREMATURITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Teaching Hospital

    RECRUITING

    Lusaka, Lusaka Province, 10100, Zambia

More trials for these conditions

Other studies related to the condition(s) this trial covers.